US · PRVA
Privia Health Group, Inc.
- Sector
- Healthcare · Medical - Healthcare Information Services
- Headquarters
- Arlington, VA 22203
- Website
- priviahealth.com
Price · as of 2025-12-31
$24.85
Market cap 2.92B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $404.26 | +1,526.8% |
| Intrinsic Value(DCF) | $3,016.98 | +12,040.76% |
| Graham-Dodd Method(GD) | $5,254.43 | +21,044.57% |
| Graham Formula(GF) | $5,508.58 | +22,067.31% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | $0.31 | $2.10 | |||
| 2020 | $1.74 | $3.53 | |||
| 2021 | $23.77 | $35.64 | $14.50 | $0.00 | $0.00 |
| 2022 | $25.81 | $40.10 | $605.17 | $2.97 | $0.00 |
| 2023 | $22.92 | $53.89 | $528.58 | $4.61 | $5.81 |
| 2024 | $25.54 | $48.07 | $107.58 | $4.74 | $1.53 |
| 2025 | $24.04 | $404.26 | $5,015.53 | $5,254.43 | $5,508.58 |
AI valuation
Our deep-learning model estimates Privia Health Group, Inc.'s (PRVA) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $404.26
- Current price
- $24.85
- AI upside
- +1,526.8%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$3,016.98
+12,040.76% upside
Graham-Dodd
$5,254.43
+21,044.57% upside
Graham Formula
$5,508.58
+22,067.31% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| PRVA | Privia Health Group, Inc. | $24.85 | 2.92B | +1,527% | +12,041% | +21,045% | +22,067% | 0.10 | 0.00 | 1.38 | -8677.07 | 0.16 | 0.01 | 9.40% | 1.61% | 1079.64% | 8.06% | 0.02% | 4.34% | 0.01 | — | 1.60 | 1.55 | -8731.62 | 6364.00% | 2226.00% | 15646682.00% | 5557.73% | 0.29 | 122.18% | 0.00% | 0.00% | 15990.70% | -13647.35 | -2.86 | -220.09 | 0.14 |
| ARQT | Arcutis Biotherapeutics, … | $26.97 | 3.3B | +86% | +93,044% | -97% | — | -195.17 | 16.63 | 8.38 | 1183.71 | — | 18.04 | 90.24% | -3.25% | -4.29% | -9.30% | -163.75% | -4.13% | 0.03 | -1.01 | 3.17 | 2.83 | -14.77 | -8879.00% | 9134.00% | -9438.00% | -0.20% | -0.04 | -84.52% | 0.00% | 0.00% | 2.41% | -240.09 | -465.16 | 7.81 | 5.64 |
| ATEC | Alphatec Holdings, Inc. | $13.62 | 2.02B | +183% | +162% | — | — | -14.10 | 56.10 | 2.65 | -62.48 | — | -15.24 | 69.60% | -10.75% | -18.76% | -630.66% | -16.83% | -18.30% | 17.21 | -3.88 | 2.06 | 1.18 | -11.57 | -1504.00% | 2495.00% | -10201.00% | 0.14% | 0.21 | 0.57% | 0.00% | 0.00% | 0.59% | -30.20 | 893.55 | 3.25 | 0.06 |
| HTFL | Heartflow, Inc. Common St… | $23.16 | 1.97B | — | — | — | — | — | — | — | — | — | — | 75.07% | -48.66% | -76.65% | 11.78% | 8.22% | -63.49% | -0.19 | -2.69 | 2.45 | 2.33 | -1.67 | -2320.00% | 4432.00% | -1112.00% | — | -2.05 | 9.85% | — | 0.00% | — | — | — | — | — |
| ICUI | ICU Medical, Inc. | $150.58 | 3.72B | -14% | -61% | -83% | -100% | 4947.86 | 1.71 | 1.62 | 14.41 | — | -381.73 | 36.76% | 4.80% | 0.03% | 0.04% | 1.32% | 0.02% | 0.66 | 1.01 | 2.36 | 0.98 | 3.32 | -10061.00% | -638.00% | -2636.00% | 2.53% | 0.36 | 2.82% | 0.00% | 0.00% | 7.11% | 44.00 | 51.26 | 2.11 | 2.21 |
| LIVN | LivaNova PLC | $70.60 | 3.86B | +8% | -48% | — | — | -15.79 | 3.19 | 2.76 | -28.32 | — | 21.61 | 67.71% | 14.36% | -17.47% | -19.24% | 15.30% | -9.49% | 0.39 | 4.04 | 1.36 | 1.05 | 1.25 | -48362.00% | 1074.00% | 2742.00% | 4.52% | 0.31 | 13.29% | 0.00% | 0.00% | 10.83% | 18.39 | 21.17 | 2.64 | 2.55 |
| NVST | Envista Holdings Corp | $29.21 | 4.8B | +59% | -47% | -80% | -85% | 105.23 | 1.59 | 1.82 | 15.93 | — | 40.91 | 55.02% | 8.30% | 1.73% | 1.56% | 2.57% | 0.85% | 0.55 | 6.17 | 2.38 | 1.93 | 1.45 | -10431.00% | 832.00% | -2389.00% | 4.66% | 0.32 | 6.57% | 0.00% | 0.00% | 3.37% | 24.11 | 23.62 | 2.00 | 1.90 |
| PBH | Prestige Consumer Healthc… | $69.30 | 3.33B | +25% | -46% | -31% | -42% | 19.70 | 2.30 | 3.72 | 14.29 | 684.50 | -4.28 | 55.76% | 29.60% | 18.86% | 12.30% | 9.20% | 6.39% | 0.57 | 7.07 | 4.20 | 2.74 | 2.61 | 288.00% | 110.00% | 164.00% | 5.76% | 2.36 | 8.80% | 0.00% | 0.00% | 4.69% | 15.36 | 21.27 | 4.55 | 3.04 |
| PINC | Premier, Inc. | $28.26 | 2.34B | — | — | — | — | — | — | — | — | — | — | 73.41% | 0.11% | 2.00% | 3.56% | 0.04% | 1.91% | 0.18 | 0.06 | 0.64 | 0.55 | 0.85 | -7885.00% | -2479.00% | 4801.00% | — | 0.44 | 17.33% | — | 124.60% | — | — | — | — | — |
| SUPN | Supernus Pharmaceuticals,… | $54.73 | 3.14B | +101% | -41% | -57% | -59% | 23.92 | 1.71 | 2.67 | 7.56 | 0.44 | 4.45 | 88.23% | 12.34% | 11.16% | 7.55% | 9.31% | 5.58% | 0.03 | — | 2.35 | 2.04 | -0.20 | 546962.00% | 894.00% | 5491.00% | 9.69% | 0.59 | 25.85% | 0.00% | 0.00% | 0.09% | 16.50 | 7.87 | 2.04 | 4.79 |
| TVTX | Travere Therapeutics, Inc… | $29.79 | 2.67B | +90% | +51,751% | — | — | -103.12 | 22.94 | 5.37 | 118.84 | — | 2744.19 | 85.51% | -12.80% | -10.24% | -29.38% | -59.63% | -4.26% | 2.86 | -5.85 | 2.74 | 2.52 | 10.61 | -8627.00% | 11045.00% | -11116.00% | 1.43% | 0.24 | 35.86% | 0.00% | 0.00% | 4.07% | -42.03 | 69.88 | 5.38 | 0.84 |
About Privia Health Group, Inc.
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.
- CEO
- Parth Mehrotra
- Employees
- 1.14K
- Beta
- 0.83
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($3,016.98 ÷ $24.85) − 1 = +12,040.76% (DCF, example).